ChromaDex Statistics
Total Valuation
ChromaDex has a market cap or net worth of $209.62 million. The enterprise value is $185.28 million.
| Market Cap | 209.62M |
| Enterprise Value | 185.28M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ChromaDex has 75.54 million shares outstanding. The number of shares has increased by 0.58% in one year.
| Shares Outstanding | 75.54M |
| Shares Change (YoY) | +0.58% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 35.79% |
| Owned by Institutions (%) | 18.00% |
| Float | 51.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 544.12 |
| PS Ratio | 2.52 |
| Forward PS | 2.03 |
| PB Ratio | 7.24 |
| P/FCF Ratio | 46.30 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 40.93 |
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.52 |
| Quick Ratio | 1.76 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.71 |
| Interest Coverage | -52.45 |
Financial Efficiency
Return on equity (ROE) is -12.60% and return on invested capital (ROIC) is -13.56%.
| Return on Equity (ROE) | -12.60% |
| Return on Assets (ROA) | -6.50% |
| Return on Capital (ROIC) | -13.56% |
| Revenue Per Employee | $784,594 |
| Profits Per Employee | -$33,283 |
| Employee Count | 106 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 2.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.78% in the last 52 weeks. The beta is 1.87, so ChromaDex's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | +56.78% |
| 50-Day Moving Average | 2.95 |
| 200-Day Moving Average | 2.24 |
| Relative Strength Index (RSI) | 49.29 |
| Average Volume (20 Days) | 640,657 |
Short Selling Information
The latest short interest is 1.87 million, so 2.47% of the outstanding shares have been sold short.
| Short Interest | 1.87M |
| Short Previous Month | 1.87M |
| Short % of Shares Out | 2.47% |
| Short % of Float | 3.62% |
| Short Ratio (days to cover) | 3.11 |
Income Statement
In the last 12 months, ChromaDex had revenue of $83.17 million and -$3.53 million in losses. Loss per share was -$0.05.
| Revenue | 83.17M |
| Gross Profit | 50.72M |
| Operating Income | -4.36M |
| Pretax Income | -3.53M |
| Net Income | -3.53M |
| EBITDA | -1.81M |
| EBIT | -3.46M |
| Loss Per Share | -$0.05 |
Balance Sheet
The company has $27.57 million in cash and $3.23 million in debt, giving a net cash position of $24.34 million or $0.32 per share.
| Cash & Cash Equivalents | 27.57M |
| Total Debt | 3.23M |
| Net Cash | 24.34M |
| Net Cash Per Share | $0.32 |
| Equity (Book Value) | 28.95M |
| Book Value Per Share | 0.38 |
| Working Capital | 29.52M |
Cash Flow
In the last 12 months, operating cash flow was $4.62 million and capital expenditures -$93,000, giving a free cash flow of $4.53 million.
| Operating Cash Flow | 4.62M |
| Capital Expenditures | -93,000 |
| Free Cash Flow | 4.53M |
| FCF Per Share | $0.06 |
Margins
Gross margin is 60.98%, with operating and profit margins of -5.24% and -4.24%.
| Gross Margin | 60.98% |
| Operating Margin | -5.24% |
| Pretax Margin | -4.24% |
| Profit Margin | -4.24% |
| EBITDA Margin | -2.17% |
| EBIT Margin | -4.16% |
| FCF Margin | 5.44% |
Dividends & Yields
ChromaDex does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.58% |
| Shareholder Yield | -0.58% |
| Earnings Yield | -1.68% |
| FCF Yield | 2.16% |
Analyst Forecast
The average price target for ChromaDex is $6.00, which is 116.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 116.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 13, 2016. It was a reverse split with a ratio of 1:3.
| Last Split Date | Apr 13, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
ChromaDex has an Altman Z-Score of 2.04 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.04 |
| Piotroski F-Score | 4 |